Integrated cell-culture based MVA virus production process with perfusion mode 
for vaccines or gene therapy

Gränicher, Gwendal; Göbel, Sven; Marichal-Gallardo, Pavel; Jordan, Ingo; Sandig, Volker; Genzel, Yvonne; Reichl, Udo

Lokale TagsFreigabegeschichteDetailsÜbersicht

Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy

Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., et al. (2022). Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapy. Talk presented at Value through intensified bioprocessing II. Oxford, United Kingdom. 2022-06-22 - 2022-06-24.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/21.11116/0000-000A-CB21-C Versions-Permalink: https://hdl.handle.net/21.11116/0000-000A-CB22-B

Genre: Vortrag

ausblenden:

Urheber:
Gränicher, Gwendal¹, Autor
Göbel, Sven¹, Autor
Marichal-Gallardo, Pavel¹, Autor
Jordan, Ingo², Autor
Sandig, Volker², Autor
Genzel, Yvonne¹, Autor
Reichl, Udo^{1, 3}, Autor

Affiliations:
1Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Max Planck Society, ou_1738140
2ProBioGen AG, Berlin, Germany , ou_persistent22
3Otto-von-Guericke-Universität Magdeburg, External Organizations, ou_1738156